Estroven Stress, Mood & Memory
Natural health product licensed in Canada
- Other names
- Estroven Mood + Memory Boost
- Licence holder
- i-Health Inc.
- NPN or DIN-HM
- 80071078
- Status
- Active licence
- Licence date
- 13 July 2016
- Revision date
- 6 June 2025
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Magnolia officinalis Rehder & E.H.Wilson: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Actaea racemosa Source : Racine Extract : Matériel brut sec Extraction ratio : 6:1 Dry plant equivalent : 240 milligramme | 40 milligramme | Not calculated |
| Glycine max Source : Glycine max - Graine Extract : Matériel brut sec Extraction ratio : 171:1 Dry plant equivalent : 23,940 milligramme Potency : 56 mg ÉAI Isoflavones | 140 milligramme | Not calculated |
| Glycine max Source : Glycine max - Graine Potency : 28 mg ÉAI | Not specified | Not calculated |
| Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 6,000 milligramme Potency : 24 % Flavonoid glycosides | 120 milligramme | Not calculated |
| Ginkgo biloba Source : Feuille Potency : 6 % Terpene lactones | Not specified | Not calculated |
| Magnolia officinalis Source : Rhizome bark Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 300 milligramme | 15 milligramme | Not calculated |
Non-medicinal ingredients
Silice, Acide stéarique, Triglycérides à chaîne moyenne, phosphate de dicalcium, Dioxyde de titane, Stéarate de magnésium, Inuline, Hydroxypropyl methyl cellulose, Jus de légumes, Croscarmellose de sodium, Talc, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Femmes ménopausées et en postménopause | Not specified | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Soy isoflavones may reduce severe and frequent menopausal symptoms (such as hot flashes and/or night sweats). Black Cohosh helps relieve symptoms associated with menopause. May help to reduce irritability associated with menopause. Ginkgo Biloba helps to enhance cognitive function and memory in adults. Black Cohosh is used in herbal medicine to help ease nervous tension (calmative).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80071078
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.